[Sounds familiar, doesn’t it? This is exactly what we’re experiencing in our society today. Big Pharma, the AMA and factions of our government have been implementing Agenda 21 for decades, unbeknownst to the masses. TMR]
by Jon Rappoport – August 25, 2017
In my work-in-progress, The Underground, here is what I wrote about Google: “They’re clever, I’ll give them that. They’re saying you can search them for any information in the world, but they’re really searching you.”
Google has decided it’s not doing enough to lead us into a better world. So now it’s going to enter the field of psychiatry.
Engadget.com: Google is “offering a medically validated, anonymous screening questionnaire for clinical depression if you search for information on the condition. This won’t definitively indicate that you’re clinically depressed, to be clear, but it will give you useful information you can take to a doctor.”
“Google and others are determined to fight fake news, and they know that the consequences of false or incomplete medical information could be serious. If you need help, they want to be sure you get the appropriate support.”
Let’s see if I can help Google fight false or incomplete medical information.
For example, be aware that there is no defining lab test for clinical depression.
No blood test, no urine test, no saliva test, no brain scan, no genetic assay.
Committees of psychiatrists sit down and look at unscientific menus of human behavior, lump certain behaviors together, and arbitrarily label them “clinical depression.”
Therefore, any Google questionnaire is simply going to feed into that trough of pseudoscience. That’s all.
Then, of course, there are the drugs that come with a diagnosis of depression. Drugs like Prozac, Paxil, Zoloft. I’ll help Google fight “incomplete medical information” in this area as well.
In 2004, Dr. Peter Breggin, eminent psychiatrist, expert witness in court trials, and author of Toxic Psychiatry, wrote the following about these drugs. I suggest paying close attention:
“On March 22  the FDA issued an extraordinary ‘Public Health Advisory’ that cautioned about the risks associated with the whole new generation of antidepressants including Prozac and its knock offs, Zoloft, Paxil, Luvox, Celexa, and Lexapro, as well as Wellbutrin, Effexor, Serzone, and Remeron. The warning followed a public hearing where dozens of family members and victims testified about suicide and violence committed by individuals taking these medications.”
“…In the debate over drug-induced suicide, little attention has been given to the FDA’s additional warning that certain behaviors are ‘known to be associated with these drugs’ including ‘anxiety, agitation, panic attacks, insomnia, irritability, hostility, impulsivity, akathisia (severe restlessness), hypomania, and mania’.”
“From agitation and hostility to impulsivity and mania, the FDA’s litany of antidepressant-induced behaviors is identical to that of PCP, methamphetamine and cocaine—drugs known to cause aggression and violence. These older stimulants and most of the newer antidepressants cause similar effects as a result of their impact on a neurotransmitter in the brain called serotonin.”
“For more than a decade, I have documented in books and scientific reports how this stimulation or activation profile can lead to out-of-control behavior, including violence…”
“As a psychiatrist and as a medical expert, I have examined dozens of cases of individuals who have committed suicide or violent crimes while under the influence of the newer antidepressants such as Prozac, Zoloft, Paxil, Luvox and Celexa. In June in South Carolina, Christopher Pittman will go on trial for shooting his grandparents to death while they slept. Chris was twelve when his family doctor started him on Zoloft. Three weeks later the doctor doubled his dose and one week later Chris committed the violent acts. In other cases, a fourteen-year-old girl on Prozac fired a pistol pointblank at a friend but the gun failed to go off, and a teenage boy on Zoloft beat to death an elderly woman who complained to him about his loud music. A greater number of cases involve adults who lost control of themselves while taking antidepressants. In at least two cases judges have found individuals not guilty on the basis of involuntary intoxication with psychiatric drugs and other cases have resulted in reduced charges, lesser convictions, or shortened sentences.”
“The FDA includes mania in its list of known antidepressant effects. Manic individuals can become violent, especially when they are thwarted, and they can also ‘crash’ into depression and suicidal states. They can carry out elaborate but grandiose and doomed plans. One clinical trial showed a rate of 6% manic reactions…on Prozac. None developed mania on a sugar pill [placebo]. Even in short-term clinical trials, 1% or more of depressed adults develop mania compared to a small fraction on the sugar pill.”
“Unfortunately, there are also risks involved with stopping antidepressants. Many can cause withdrawal reactions that last days and sometimes longer, causing some patients to feel depressed, suicidal or even violent. Stopping antidepressants should be done carefully and with experienced clinical supervision.”
“…the FDA and the medical profession must forthrightly educate potential patients and the public about the sometimes life-threatening risks associated with the use of antidepressant medications.”
Here is the kicker. Google can do anything it wants to with the information in this article, the one you’re now reading. It can lower its ranking.
Google can control the flow of information.
Given that Google has that kind of power, I strongly suggest caution when it touts its own “depression questionnaire.”
It’s not only rigging the system, it is the system.
- Deaths from prescription opioids have quadrupled since 1999
- OxyContin manufacturer Purdue Pharma paid out one of the largest pharmaceutical settlements in U.S. history after lying about addiction risks
- Nearly 260 million opioid prescriptions are written in the U.S. each year
By Dr. Mercola
The HBO documentary “Warning: This Drug May Kill You,” details the devastating effect America’s pharma-driven opioid crisis is having on families and the victims themselves. The film, made by Perri Peltz and Sascha Weiss, features the perspectives of four families whose lives have been ripped apart as a result of opioid and heroin addiction.
Opioid and heroin addiction — which public health officials have described1 as being the worst drug crisis in American history — affects about 2.5 million Americans, nearly half a million of whom are addicted to heroin,2 a dangerous street drug that prescription pill addicts can quickly turn to because the cost is significantly less than that of prescription painkillers.
The term “opioid” is used to describe a class of drugs that includes the illegal drug heroin, as well as the legal prescription painkillers oxycodone, hydrocodone, codeine, morphine, fentanyl and others. Ironically, the silent but deadly opioid epidemic often starts with some of society’s most trusted professionals: doctors.
As noted in the film, a significant number of opioid addictions begin with a trip to the doctor’s office or a hospital as a result of an injury or medical problem for which addictive painkillers are carelessly prescribed. It seems no medical problem is too minor for powerful prescription painkillers to be prescribed.
This is depicted in the film, which details the story of a young woman from Beach Park, Illinois, who became addicted to OxyContin after being prescribed the medication for kidney stones. Not only are opioid pain medications (also called narcotic prescription painkillers) wildly overprescribed, but they are also often given without warning of the potential risks for addiction and/or resources to help deal with the possible risk of addiction.
Nearly 260 Million Opioid Prescriptions Are Written in the US Each Year
The number of opioid prescriptions has increased substantially over the last few decades. “In 2012, 259 million prescriptions were written for opioids, which is more than enough to give every American adult their own bottle of pills,” according to the American Society of Addiction Medicine.3
The result? Drug overdose is now our nation’s leading cause of accidental death. In 2015, accidental drug overdoses accounted for 52,404 deaths, with 20,101 of those deaths related to prescription pain relievers, and 12,990 linked to heroin. However, 80 percent of heroin users start out on prescription opioids.4
Despite the fact that Americans are dying at unprecedented rates due to Big Pharma’s prescription painkillers, the pharmaceutical industry is rarely named by the establishment media for its deadly role in the growing opioid epidemic.
Kidney Stone Pain Morphs Into Deadly Opioid Addiction for Unsuspecting Teen
Stephany Gay should have been getting her license and learning how to drive when she first became addicted to prescription painkillers. It all began when, at the tender age of 16, she started suffering from kidney stones and was prescribed OxyContin and Vicodin. It didn’t take long before Stephany, who had never done illegal drugs, developed a full-blown dependency on opioids.
The teen confided in her mom after realizing she had developed an addiction. Her mother urged her to see a doctor, but when she did she came home with another prescription: This time it was for Percocet. Stephany also got her younger sister, Ashley, addicted to opioids after offering her the medication for headaches and a better night’s sleep. Stephany’s doctor eventually stopped prescribing her opioids, causing the sisters to turn to heroin to get their fix. Stephany says:
“It made me feel like I could do anything. I felt like superwoman. I didn’t have anxiety. I didn’t feel depressed. I felt happy. I felt warm. I felt like it loved me and I loved it back. I felt like I had a relationship with heroin.”
The sisters snorted heroin for a year before experimenting with a needle. Soon after Stephany started injecting, she lost the three-bedroom home she owned and custody of her young daughter. Ashley, who once told her mother she was “too pretty to die,” overdosed on heroin and died alone in a hotel room.
Eighty Percent of Heroin Users Start With Prescription Opioids
Part two of the documentary, “Addicted to Pills,” details the heartbreaking story of a wife and mother of five children who became addicted to opioids after being prescribed the medication for a Cesarean section. Wynne Doyle, from Mill Valley, California, stopped getting out of bed just one and a half months after giving birth to her third child.
She became addicted fast, says Britt Doyle Sr., who later divorced his wife following years of addiction. Like many opioid addicts, Wynne went in and out of rehab multiple times, only to relapse again. The second rehab she entered was three times as costly as the first, says Britt Sr. But 28 days later his wife returned home with a “whole bunch of pills,” and her addiction started all over again, he says.
Wynne’s addiction grew so intense that she would purposely injure herself in order to get more pills. “I watched her slam her hand in the car door one time, just so she could go to the emergency room,” said Britt Sr., adding that the doctors would always give his wife more pain medication. At one point, Wynne had shattered both of her wrists, but as soon as they healed she would hurt herself again just to get more pills. My wife became a “totally different person,” says Britt Sr. “It was like Jekyll and Hyde.”
Seven years into her addiction and on his wife’s 11th stint in rehab, Britt Sr. had finally had enough. He moved the children out of the house and filed for divorce. Sometime later, Wynne, suffering from kidney stones, was prescribed more painkillers. She had eight bottles filled to the top sitting on her nightstand when her children found their mother lifeless in her bed.
“When I saw the pills on her bedside table when she had passed, that was probably the most anger I could feel, ever, because she’s been to that hospital easily like 50 times,” said Britt Doyle Jr., Wynne’s daughter. “They’ve seen her there unconscious and had to like [sic] pump her stomach so many times. And yet she comes in there and they leave her with more?” she asks angrily.
Adolescents Are 33 Percent More Likely to Misuse Opioids as Young Adults
Part three of the documentary tells the story of Brendan Cole from Allendale, New Jersey. The teen was prescribed opioid painkillers after having a cyst surgically removed. Four years later he died of a heroin overdose. Before his death, Cole overdosed on heroin but was revived with Narcan after his dad woke in the middle of the night to find his son lying in an unnatural position on his bed.
His lips were turning blue and “we heard the air come out of his lungs when we moved him,” said his parents tearfully. Narcan, or naloxone, is an overdose-reversal drug. It’s made by Amphastar Pharmaceuticals, which began what appears to be a clear case of price gouging, raising the cost of Narcan by as much as 100 percent.
Cole recovered from the overdose, but the hospital failed to warn his family that patients revived with Narcan may experience intense cravings and withdrawal symptoms. As a result, no plan was put in place to help Cole overcome the cravings that would soon follow. The very next day, Cole overdosed again, and this time he could not be revived.
5In people with little drug experience, scientists theorize that “the initial experience of pain relief is pleasurable, and a safe initial experience with opioids may reduce perceived risk.”
Synthetic Opioids Sold Via ‘Dark Web’ Implicated in Growing Number of Overdose Deaths
In addition to prescription opioids, another threat looms: synthetic (and illegal) opioids sold through the dark web — the secret underbelly of the internet, initially created by American intelligence agencies for encrypted communication purposes. A recent piece by The New York Times6 sheds light on an emerging illicit drug trade involving dangerous synthetic opioids that are being shipped into the U.S. via small packages in the mail.
The report reveals “that most of the illicit supply of synthetic opioids is produced in labs in Asia and especially China, where many of the precursor chemicals are either legal or easier to procure.” The synthetic opioids are said to be so potent that they “have become the fastest-growing cause of the overdose epidemic, overtaking heroin in some areas,” reports the Times.
Synthetic opioids being shipped overseas include fentanyl, the infamous drug responsible for pop icon Prince’s death. Fentanyl is so potent that two milligrams is enough to kill and, unlike prescription pills, “enough fentanyl to get nearly 50,000 people high can fit in a standard first-class envelope,” the report warns.
Synthetic opioids obtained through the internet are responsible for the deaths of two teenagers from Park City, Utah. Grant Seaver and Ryan Ainsworth, both 13 years old, died after taking a synthetic opioid known as U-47700, or Pinky. The boys reportedly obtained the drug from another teen who purchased them on the dark web using bitcoin. While synthetic opioids account for a small portion of overall trafficked drugs, law enforcement says “that dark web markets have quickly assumed a more prominent and frightening role.”
Opioids Actually Alter Your Brain Structure
Studies also suggest that drugs for physical and emotional pain may change your brain. In a study by researchers at the University of Alabama, people with chronic low back pain received either morphine or a placebo daily for one month. Both groups experienced similar reductions in pain, but there was a major difference among those taking morphine — changes in the brain.
Magnetic resonance imaging (MRI) scans showed the patients taking morphine had a 3 percent reduction in gray matter volume over the course of the study. The reductions occurred in regions of the brain that regulate emotions, cravings and pain response.7
Further, the morphine group had increases in gray matter volume in areas related to learning, memory and executive function. Lead study author Joanne Lin told Reuters,8 “Because we are seeing that opioids rapidly change the brain, our take-home message is that opioids should be reserved for cases when most other treatment options have failed.”
Millions of Taxpayer Dollars Used for Opioid Prescriptions
The Centers for Medicare & Medicaid Services (CMS) is a branch of the Department of Health and Human Services. CMS runs the Medicare program and monitors Medicaid programs run by the states. According to the Office of the Inspector General (OIG), spending on opioids in the Medicare system, which is funded by U.S. tax dollars through Medicare trust funds, grew at a faster rate than spending for all drugs.
Data from the OIG shows that between 2006 and 2014, the number of Medicare recipients on opioids grew by 92 percent, compared to 68 percent for all drugs. Medicare recipients are also receiving multiple prescriptions for opioids for reasons other than cancer pain or terminal illness, the traditional uses for these strong medications.
Medicaid programs, supported by taxpayers but administered by states, also reveal excessive opioid use and probable fraud.9 In 2010, 359,368 Medicaid enrollees received an opioid prescription amounting to over 2 million prescriptions, and again suggesting many prescriptions per patient.10
While Medicaid programs likely provide generic combinations of the active ingredient in OxyContin, hydrocodone, to patients, which costs about $28 for a 120-day supply (compared with $632 for the brand name OxyContin),11 taxpayers are still paying at least $56 million for Medicaid opioid prescriptions. The cost of the opioid prescriptions does not take into consideration state-run drug treatment programs and services that are required if and when enrollees become addicted.
OxyContin Manufacturer Pays One of the Largest Pharma Settlements in US History
In December 2015, Purdue Pharmaceuticals, the maker of OxyContin, settled an ongoing lawsuit brought by the state of Kentucky for $24 million over presenting OxyContin as “nonaddictive.”12 Purdue contended that the pill slowly releases the drug over 12 hours when swallowed, omitting the fact that, when crushed, OxyContin lost its time release protections and created an instant high.
“State officials said that led to a wave of addiction and increased medical costs across the state, particularly in eastern Kentucky where many injured coal miners were prescribed the drug,” reported The Associated Press.
The 2015 settlement is similar to one Purdue agreed to in 2007 with the state of West Virginia, when it agreed to pay out $634 million because “fraudulent conduct caused a greater amount of OxyContin to be available for illegal use than otherwise would have been available.”13 Despite the lawsuits, OxyContin remains on the market.
FDA Orders Drugmaker to Stop Selling Opioid Painkiller
Opioid manufacturer Endo Pharmaceuticals hasn’t been so lucky, however. In an unprecedented move by the Food and Drug Administration (FDA), health officials have ordered Endo to remove the opioid painkiller Opana ER from the market due to the conclusion that “the drug’s risks outweigh its benefits,” reported CBS News.14
“It’s the first time the FDA has asked a drugmaker to remove an opioid painkiller from the market,” CBS said. “The agency said it has seen a ‘significant shift’ from people crushing and snorting Opana ER to get high to injecting it.” If the drugmaker refuses to comply with the FDA’s request to pull the opioid from the market, the agency can begin a “formal process for rescinding its approval.”
Drug Companies Try to Cash in on Opioid Epidemic
While an increasing number of Americans suffer the devastating effects of opioid addiction, pharmaceutical companies are battling it out to become the top seller of addiction medications. As was highlighted in a recent NPR report,15 rather than working to make various effective treatments for opioid addiction more readily available to those who need it, the pharmaceutical industry is actively trying to stomp out its competitors by restricting access to important addiction medications.
One example of this includes the global biopharmaceutical company Alkermes and its non-opioid addiction medication, Vivitrol, a monthly injection that costs around $1,000. Alkermes, based in Waltham, Massachusetts, is working vigorously to promote its drug at the legislative level as a solution to our nation’s growing opioid epidemic — and while doing so (in some cases) is restricting access to other opioid addiction medications through policy that makes it harder for doctors to prescribe alternatives to Vivitrol.
“An investigation by NPR and Side Effects Public Media has found that in statehouses across the country, and in Congress, Alkermes is pushing Vivitrol while contributing to misconceptions and stigma about other medications used to treat opioid addiction,” NPR reports.
Experts disagree about which opioid addiction medications are most effective. Some argue opioid maintenance drugs like methadone and buprenorphine — both of which contain opioids — are fueling the opioid crisis due to their street value and the idea that offering them to addicts means replacing one opioid for another. Others argue that opioid maintenance medications relieve painful withdrawal symptoms and reduce or eliminate intense cravings.
Federal health agencies and the American Society of Addiction Medicine agree that “opioid abstinence can be dangerous,” says NPR. While there are no studies comparing Vivitrol to methadone or buprenorphine, Alkermes touts Vivitrol as the more effective, opioid-free solution.
Alkermes has significantly increased its spending on federal lobbying, spending $4.4 million in 2016 compared to less than $200,000 in 2010. “Last year, Vivitrol’s sales reached $209 million — up from just $30 million in 2011,” NPR reports, adding that Alkermes projects sales could reach $1 billion by 2021.
Treating Your Pain Without Drugs
While opioid painkillers may relieve pain temporarily, the addiction risks can quickly send you spiraling out of control down a dark and dangerous path. As shown in the film, many families touched by opioid addiction end up suffering for years before finally losing a loved one to addiction.
The good news is there are many natural alternatives to treating pain. It’s particularly important to avoid opioids when trying to address long-term chronic pain, as your body will create a tolerance to the drug. Over time, you may require greater doses at more frequent intervals to achieve the same pain relief. This is a recipe for disaster and could have lethal consequences. Following is information about non-drug remedies, dietary changes and bodywork interventions that can help you manage your pain.
Kratom (Mitragyna speciose) is a plant remedy that has become a popular opioid substitute.17 In August 2016, the DEA issued a notice saying it was planning to ban kratom, listing it as a Schedule 1 controlled substance. However, following massive outrage from kratom users who say opioids are their only alternative, the agency reversed its decision.18
Kratom is safer than an opioid for someone in serious and chronic pain. However, it’s important to recognize that it is a psychoactive substance and should be used carefully. There’s very little research showing how to use it safely and effectively, and it may have a very different effect from one person to the next. The other issue to address is that there are a number of different strains available with different effects.
Also, while it may be useful for weaning people off opioids, kratom is in itself addictive. So, while it appears to be a far safer alternative to opioids, it’s still a powerful and potentially addictive substance. So please, do your own research before trying it.
Low-Dose Naltrexone (LDN)
Naltrexone is an opiate antagonist, originally developed in the early 1960s for the treatment of opioid addiction. When taken at very low doses LDN, available only by prescription, triggers endorphin production, which can boost your immune function and ease pain.
A primary therapeutic compound identified in the spice turmeric, curcumin has been shown in more than 50 clinical studies to have potent anti-inflammatory activity. Curcumin is hard to absorb, so best results are achieved with preparations designed to improve absorption. It is very safe and you can take two to three every hour if you need to.
One of the most effective oil-soluble antioxidants known, astaxanthin has very potent anti-inflammatory properties. Higher doses are typically required for pain relief, and you may need 8 milligrams or more per day to achieve results.
Also known as boswellin or “Indian frankincense,” this herb contains powerful anti-inflammatory properties, which have been prized for thousands of years. This is one of my personal favorites, as it worked well for many of my former rheumatoid arthritis patients.
This protein-digesting enzyme, found in pineapples, is a natural anti-inflammatory. It can be taken in supplement form, but eating fresh pineapple may also be helpful. Keep in mind most of the bromelain is found within the core of the pineapple, so consider eating some of the pulpy core when you consume the fruit.
Also called capsaicin cream, this spice comes from dried hot peppers. It alleviates pain by depleting your body’s supply of substance P, a chemical component of nerve cells that transmit pain signals to your brain.
Cetyl myristoleate (CMO)
This oil, found in dairy butter and fish, acts as a joint lubricant and anti-inflammatory. I have used a topical preparation of CMO to relieve ganglion cysts and a mild case of carpal tunnel syndrome.
Evening primrose, black currant and borage oils
These oils contain the fatty acid gamma-linolenic acid, which is useful for treating arthritic pain.
This herb is anti-inflammatory and offers pain relief and stomach-settling properties. Fresh ginger works well steeped in boiling water as a tea, or incorporated into fresh vegetable juice.
Dietary Changes to Fight Inflammation and Manage Your Pain
Unfortunately, physicians often fall short when attempting to effectively treat chronic pain, resorting to the only treatment they know: prescription drugs. While these drugs may bring some temporary relief, they will do nothing to resolve the underlying causes of your pain. If you suffer from chronic pain, making the following changes to your diet may bring you some relief.
|Consume more animal-based omega-3 fats. Similar to the effects of anti-inflammatory pharmaceutical drugs, omega-3 fats from fish and fish oils work to directly or indirectly modulate a number of cellular activities associated with inflammation. While drugs have a powerful ability to inhibit your body’s pain signals, omega-3s cause a gentle shift in cell signaling to bring about a lessened reactivity to pain.
Eating healthy seafood like anchovies or sardines, which are low in environmental toxins, or taking a high-quality supplement such as krill oil are your best options for obtaining omega-3s. DHA and EPA, the omega-3 oils contained in krill oil, have been found in many animal and clinical studies to have anti-inflammatory properties, which are beneficial for pain relief.
|Radically reduce your intake of processed foods. Processed foods not only contain chemical additives and excessive amounts of sugar, but also are loaded with damaging omega-6 fats. By eating these foods, especially fried foods, you upset your body’s ratio of omega-3 to omega-6 fatty-acids, which triggers inflammation. Inflammation is a key factor in most pain.|
|Eliminate or radically reduce your consumption of grains and sugars. Avoiding grains and sugars, especially fructose, will lower your insulin and leptin levels. Elevated insulin and leptin levels are some of the most profound stimulators of inflammatory prostaglandin production, which contributes to pain.
While healthy individuals are advised to keep their daily fructose consumption below 25 grams from all sources, you’ll want to limit your intake to 15 grams per day until your pain is reduced. Eating sugar increases your uric acid levels, which leads to chronic, low-level inflammation.
|Optimize your production of vitamin D. As much as possible, regulate your vitamin D levels by regularly exposing large amounts of your skin to sunshine. If you cannot get sufficient sun exposure, taking an oral vitamin D3 supplement, along with vitamin K2 and magnesium, is highly advisable.
Research by GrassrootsHealth suggests adults need about 8,000 IUs per day to achieve a serum level of 40 ng/ml, but you may need even more. It’s best to get your blood level tested to be sure you’re safely within the therapeutic range.
Bodywork Methods That Reduce Pain
Due to the inherent risks of addiction and the other unpleasant side effects of prescription painkillers, I recommend you pursue one or more of the following bodywork methods before taking a narcotic for pain. Each one has been demonstrated to be an effective treatment for lasting pain relief and management.
•Acupuncture: According to The New York Times,19 an estimated 3 million American adults receive acupuncture annually, most often for the treatment of chronic pain. A study20 published in the Archives of Internal Medicine concluded acupuncture has a definite effect in reducing four types of chronic pain, including back and neck pain, chronic headache, osteoarthritis and shoulder pain — more so than standard pain treatment.
•Chiropractic adjustments: While previously used most often to treat back pain, chiropractic treatment addresses many other problems — including asthma, carpal tunnel syndrome, fibromyalgia, headaches, migraines, musculoskeletal pain, neck pain and whiplash. According to a study21 published in the Annals of Internal Medicine, patients with neck pain who used a chiropractor and/or exercise were more than twice as likely to be pain-free in 12 weeks compared to those who took medication.
•Massage: Massage releases endorphins, which help induce relaxation, relieve pain and reduce levels of stress chemicals such as cortisol and noradrenaline. A systematic review and meta-analysis22 published in the journal Pain Medicine, included 60 high-quality and seven low-quality studies that looked into the use of massage for various types of pain, including bone and muscle, fibromyalgia, headache and spinal-cord pain.
The study revealed massage therapy relieves pain better than getting no treatment at all. When compared to other pain treatments like acupuncture and physical therapy, massage therapy still proved beneficial and had few side effects. In addition to relieving pain, massage therapy also improved anxiety and health-related quality of life.
•Emotional Freedom Techniques (EFT): EFT continues to be one of the easiest and most effective ways to deal with acute and chronic pain. The technique is simple and can be applied in mere minutes, helping you to overcome all kinds of bodily aches and pains. A study23 published in Energy Psychology examined the levels of pain in a group of 50 people attending a three-day EFT workshop, and found their pain dropped by 43 percent during the workshop.
Six weeks later, their pain levels were reported to be 42 percent lower than before the workshop. As a result of applying EFT, participants felt they had an improved sense of control and ability to cope with their chronic pain. In the video featured below, EFT expert Julie Schiffman, teaches you how to use EFT to address chronic pain.
[Take note, pill popping America: More than 3 decades ago Iatrogenic Illness (caused by doctors, hospitals and medications) was made public but nobody seemed to care. TMR]
by Jon Rappoport
July 4, 2017
You can have Obamacare. Or you can take the current Republican re-do. Have you read it? Do you know exactly what’s in it? Of course not.
I can tell you this. Every possible healthcare bill has the same flaw. It’s called death. I’ll explain in a moment.
But first I want to mention that, for the past decade, as a working reporter, I’ve taken many actions to put a piece of medical information in front of mainstream news media, and they won’t bite. No matter what. I’ve published the information, backed it up seven ways from Sunday, and it doesn’t matter. No dice.
Here it is. Again. Every year, like clockwork, the US medical system kills 225,000 people. That’s a mainstream conclusion. A conservative conclusion. By extrapolation, that means the US medical system kills 2.25 MILLION people per decade.
Therefore, any new law that places more Americans inside the medical system through insurance plans will increase those death numbers. The death numbers will rise to new heights.
Where does the 225,000 death figure come from? A review in the July 26, 2000, Journal of the American Medical Association, titled: “Is US Health really the Best in the World?” The author was Dr. Barbara Starfield, a revered public health expert at the Johns Hopkins School of Public Health.
When I interviewed her in 2009, not long before her death, I asked whether the federal government was doing anything to comprehensively fix the medical horror show, and whether any official from the government had approached her to consult on that fix. To both questions, she emphatically answered: “NO.”
In her Journal review, Starfield broke down the ongoing medical tragedy this way: annually, 106,000 Americans die from the effects of correctly prescribed, FDA approved, medicines. 119,000 Americans die as a result of mistreatment and errors in hospitals.
Again, it doesn’t matter what kind of national health insurance plan you prefer. As long as it puts more Americans under the umbrella of the medical system, the death figures will rise.
Starfield was not the only person to blow the whistle. I’ll give you two more examples.
Consider this article, “The Epidemic of Sickness and Death from Prescription Drugs.” The author is Donald Light, who teaches at Rowan University, and is the 2013 recipient of ASA’s [American Sociological Association’s] Distinguished Career Award for the Practice of Sociology. Light is a founding fellow of the Center for Bioethics at the University of Pennsylvania. In 2013, he was a fellow at the Edmond J. Safra Center for Ethics at Harvard. He is a Lokey Visiting Professor at Stanford University.
Donald Light: “Epidemiologically, appropriately prescribed, prescription drugs are the fourth leading cause of death, tied with stroke at about 2,460 deaths each week in the United States. About 330,000 patients die each year from prescription drugs in the United States and Europe. They [the drugs] cause an epidemic of about 20 times more hospitalizations [than the deaths: 6.6 million hospitalizations annually], as well as falls, road accidents, and [annually] about 80 million medically minor problems such as pains, discomforts, and dysfunctions that hobble productivity or the ability to care for others. Deaths and adverse effects from overmedication, errors, and self-medication would increase these figures.” (ASA publication, “Footnotes,” November 2014)
One more. The journal citation is: BMJ June 7, 2012 (BMJ 2012:344:e3989), “Anticoagulants cause the most serious adverse events, finds US analysis.” Author, Jeanne Lenzer.
Lenzer refers to a report by the Institute for Safe Medication Practices: “It calculated that in 2011 prescription drugs were associated with two to four million people in the US experiencing ‘serious, disabling, or fatal injuries, including 128,000 deaths.'”
The report called this “one of the most significant perils to humans resulting from human activity.”
by Jon Rappoport
May 9, 2017
The drug was approved, by the FDA, for public use in 1993, to treat schizophrenia, a “mental disorder” for which there is no defining diagnostic test. No blood test, no saliva test, no brain scan, no genetic assay.
In 2006, the FDA approved Risperdal to treat “irritability” in autistic children. There is no defining diagnostic test for autism. The neurological damage involved can come from any cause—especially vaccines. But of course, all public health agencies deny this fact.
In 2007, the FDA approved Risperdal to treat bipolar disorder in children between the ages of 10 and 17. Bipolar is another “mental disorder” for which there is no defining diagnostic test.
Risperdal was approved to treat three conditions, which are diagnosed by casually observing a patient’s behavior and comparing it to a menu of behaviors called schizophrenia, bipolar, and autism.
If the drug had no adverse effects, that would be one thing; but it has devastating effects. Tardive dyskinesia, a permanent “movement disorder” that signals brain damage. Suicide. Gynecomastia—boys grow female breasts.
Before I go on, NOTE: Rapid withdrawing from psychiatric drugs can have disastrous effects. See Dr. Peter Breggin on this subject.
Now let’s get to the lawsuits against Johnson & Johnson, Risperdal’s manufacturer:
2012: J&J fined $1.2 billion for hiding adverse effects of the drug. Decision overturned on appeal.
2012: J&J paid out $181 million for actively promoting off-label uses for Risperdal. Doctors are permitted to prescribe a drug for unapproved uses, but drug companies cannot legally promote or urge doctors to wander into that off-label territory.
2015-2016: There are at least 1500 suits against J&J for causing boys to grow female breasts. Thus far, three verdicts have been decided in favor of the boys, for $1.75 million, $2.5 million, and $70 million.
The story of Risperdal expands and explodes when we consider the marketing effort behind it. Basically, the hustle involved claims that the drug could be used to treat a wide array of so-called disorders in children.
I will now quote extensively from a classic article written at madinamerica.com, by Paula J Caplan, PhD. The title of her article (10/30/2015) is “Diagnosisgate: A Major Media Blackout Mystery”:
“Until their identities are widely exposed, and their motives are known, the full story of the [Risperdal] harm will never be known. It is astonishing that despite six stories in the major media – including a recent, groundbreaking Huffington Post series – and the filing of numerous lawsuits, the names and conduct of the culprits have consistently been omitted.”
“The story that has been called ‘Diagnosisgate’ starts in 1995, when the man widely considered the world’s most important psychiatrist split a payoff of nearly one million dollars with two colleagues in exchange for doing two patently unethical and illegal things that created the groundwork for a major drug company to market falsely one of the most dangerous psychoactive drugs [Risperdal].”
“Part one: In return for almost half a million dollars, they ignored what was known about the drug [Risperdal] in order to manufacture a practice guideline holding up that drug as the best drug among two whole classes of related drugs for treating people who were classified as ‘schizophrenic,’ the other drugs being marketed by other drug companies. This created what is widely considered the ‘standard of care,’ the treatment that therapists are supposed to follow and that they can use in the knowledge that they are well protected from lawsuits if they follow it and their patients are harmed. The very foundation of the guideline, that it was about ‘Schizophrenia,’ is illegitimate, because – though this will surprise many people – that category has been shown to be unscientifically created and indeed has been called a wastebasket for a wide variety of feelings and behavior, many of which are caused by psychiatric drugs.”
“Part two: After the triumvirate received a bonus of $65,000 for creating the guideline [‘treat schizophrenia with Risperdal’] speedily, their top psychiatrist wrote to the same drug company, announcing that the three had constituted themselves as an entity that was prepared, in return for about another half million dollars, to create a marketing plan for the drug. The details included finding ‘key opinion leaders’ (KOLs), who were prominent professionals in powerful positions – such as heads of state mental health or prison systems – and having them teach the Continuing Education courses that professionals are required to take, the ultimate message of those courses being that that particular drug [Risperdal] was the best one to prescribe. Another section of their marketing plan was to have a great many articles published in what are considered scientific or medical journals, all concluding that that drug was effective and should be prescribed.”
“It is not clear whether the three psychiatrists were directly involved in choosing the content of the journal articles, but the plan to produce such articles was carried out, leading to publication of pieces recommending use of the drug [Risperdal] to treat not only Schizophrenia but also Childhood Onset Schizophrenia, Schizo-affective Disorder, Bipolar Disorder in Children and Adults, Mania, Autism, Pervasive Developmental Disorder other than Autism, Conduct Disorder, Oppositional Defiant Disorder, Psychosis, Aggression Agitation, Dementia, below average IQ, and disruptive behavior. Thus, a staggering array of psychiatric categories – many of which are as scientifically sketchy as Schizophrenia – was used to promote the drug. This massive marketing campaign proceeded despite the many major negative effects of Risperdal, including drowsiness, dizziness, nausea, vomiting, diarrhea, constipation, heartburn, dry mouth, increased saliva production, increased appetite, weight gain, stomach pain, anxiety, agitation, restlessness, difficulty falling asleep or staying asleep, decreased sexual interest or ability, vision problems, muscle or joint pain, dry or discolored skin, difficulty urinating, muscle stiffness, confusion, fast or irregular pulse, sweating, unusual and uncontrollable movements of face or body, faintness, seizures, Parkinsonian symptoms such as slow movements or shuffling walk, rash, hives, itching, difficulty breathing or swallowing, gynecomastia in male children, painful erection of penis lasting for hours…and death.”
“Who are the characters in this mystery? Janssen Pharmaceuticals, a division of Johnson & Johnson, is the drug company, and Risperdal is the drug in question. The marketing term for Risperdal and similar drugs is ‘anti-psychotic,’ but the accurate term is ‘neuroleptic,’ reflecting the mechanism of suppressing the brain’s activity as a powerful tranquilizer. Dr. David Rothman, who wrote the expert witness report for one of the lawsuits about the marketing of Risperdal, revealed after scrupulous examination of vast numbers of internal emails between Janssen staff and the representative of the three psychiatrists, is a specialist in medical ethics and the Bernard Schoenberg Professor of Social Medicine at Columbia College of Physicians and Surgeons, the medical school of Columbia University. He is also director of the Center for the Study of Science and Medicine at Columbia and at the time of writing his expert witness report was president of the Institute on Medicine as a Profession. Rothman stated in his report that the [treatment] guidelines [for Risperdal] were constructed ‘in disregard of professional medical ethics and principles of conflict of interest,’ and that they ‘subverted scientific integrity, appearing to be a purely scientific venture when it was at its core, a marketing venture for Risperdal’.”
“The psychiatrist who spearheaded these [Risperdal marketing] efforts is Dr. Allen Frances, who the year before teaming with Janssen oversaw the publication of the fourth volume of the ‘Bible’ of hundreds of categories of mental illness, Diagnostic and Statistical Manual of Mental Disorders, sales of which topped $100 million as a result of marketing by the lobby group called the American Psychiatric Association, which published it. By virtue of this position, he has been called the world’s most important psychiatrist. At the time, he was also Chair of the Department of Psychiatry at Duke University. The two psychiatrists who with Frances shared the nearly $1 million in payments from Janssen are Dr. John P. Docherty, who was then Professor and Vice Chairman of Psychiatry at Cornell University at the time, and Dr. David A. Kahn, who was Associate Clinical Professor of Psychiatry at Columbia University.”
“Now back to the mystery: Despite five individual stories in major media outlets in 2011, 2012, and 2014 about two huge Risperdal court cases filed by the state of Texas and joined by many other states, neither a single writer of any of these stories nor even the papers filed for the court cases named Frances, Docherty, or Kahn or described the fundamental roles played by their Practice Guideline and their marketing plan in the scandal. The mystery is deepened, because the authors of the media stories and the court documents did name and describe the roles of some of the KOLs [key opinion leaders], who assuredly were guilty of unethical conduct but whose participation was conceived of by Frances and his colleagues. And some of those who reaped huge financial profits from Risperdal’s false marketing – most notably Harvard University’s Dr. Joseph Biederman, who created an empire based on claims that ‘Bipolar Disorder in Children’ had been woefully underdiagnosed and untreated – have been royally outed for the enormous sums they earned. But even respected investigative journalist Steve Brill, who recently completed a unique, 15-part story of the Risperdal scandal for Huffington Post, and who described in detail many of its players and some of the patients who suffered terrible harm from the drug and who elegantly described the way that Janssen covered up data about some of the harm, left out the essential roles the Frances triumvirate played. Activist Vera Sharav of the Alliance for Human Research Protection published an online article about the Rothman Report and included the names of Frances and those two colleagues, her article was apparently picked up by only two or three bloggers and none of the major media reporters who read what she posts.”
There is more. Much more. I suggest you read Caplan’s entire article. In a half-sane world, she would have been awarded the highest possible honors for her work.
Risperdal. The long and winding trail. The severe damage. The hustle, the con. The crimes.
The lack of criminal prosecutions.
Brought to you by high authorities in the psychiatric profession and their allies.
A public revolt against the drugs and the pushers is necessary to stem the tide of poisoning.
(Note: for the links to the sources for this story, click here.)